US6790965B1
(en)
|
1994-05-06 |
2004-09-14 |
Pharmacopeia Drug Discovery, Inc. |
Combinatorial dihydrobenzopyran library
|
DE19610103A1
(de)
|
1996-03-15 |
1997-09-18 |
Basf Ag |
Cycloalkylderivate und ihre Synthese an fester Phase
|
DE19621177A1
(de)
|
1996-05-24 |
1997-11-27 |
Basf Ag |
Kohlenhydratderivate und ihre Synthese an fester Phase
|
DE19626762A1
(de)
|
1996-07-03 |
1998-01-08 |
Basf Ag |
Enzymatisch spaltbare Linker für Festphasensynthesen
|
US6664258B1
(en)
|
1996-08-26 |
2003-12-16 |
Pfizer Inc |
Spirocyclic dopamine receptor subtype ligands
|
US5908960A
(en)
*
|
1997-05-07 |
1999-06-01 |
Smithkline Beecham Corporation |
Compounds
|
US6004823A
(en)
*
|
1997-05-07 |
1999-12-21 |
Smithkline Beecham Corporation |
Compounds
|
EP0905512A1
(fr)
*
|
1997-09-25 |
1999-03-31 |
Cerep |
Méthode pour l'identification des structures de base ou composés actifs
|
US6362009B1
(en)
|
1997-11-21 |
2002-03-26 |
Merck & Co., Inc. |
Solid phase synthesis of heterocycles
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
US5976813A
(en)
*
|
1997-12-12 |
1999-11-02 |
Abbott Laboratories |
Continuous format high throughput screening
|
NZ552959A
(en)
|
1998-11-27 |
2008-06-30 |
Darwin Discovery Ltd |
Compositions and methods for increasing bone mineralization
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
UA81216C2
(en)
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
US6906067B2
(en)
|
1999-12-28 |
2005-06-14 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of TNF-α expression
|
EP1254369B1
(fr)
|
2000-02-08 |
2010-10-06 |
Sangamo BioSciences, Inc. |
Cellules destinees a la decouverte de medicaments
|
US6511808B2
(en)
|
2000-04-28 |
2003-01-28 |
Sangamo Biosciences, Inc. |
Methods for designing exogenous regulatory molecules
|
US7923542B2
(en)
|
2000-04-28 |
2011-04-12 |
Sangamo Biosciences, Inc. |
Libraries of regulatory sequences, methods of making and using same
|
AU2001255748B2
(en)
|
2000-04-28 |
2006-08-10 |
Sangamo Therapeutics, Inc. |
Methods for binding an exogenous molecule to cellular chromatin
|
WO2001084148A2
(fr)
|
2000-04-28 |
2001-11-08 |
Sangamo Biosciences, Inc. |
Pharmacogenomique et identification de cibles medicamenteuses par reconstruction des voies de transduction du signal a partir de sequences des regions accessibles
|
ATE374249T1
(de)
|
2000-04-28 |
2007-10-15 |
Sangamo Biosciences Inc |
Datenbanken von regulatorischen sequenzen, methoden zu ihrer herstellung und verwendung
|
DK2026073T3
(en)
|
2000-04-29 |
2016-07-25 |
Univ Iowa Res Found |
Diagnosis and treatment of macular degeneration-related disorders
|
AU2001289831A1
(en)
*
|
2000-09-06 |
2002-03-22 |
Bayer Aktiengesellschaft |
Medicaments against viral infections
|
WO2002040874A1
(fr)
|
2000-11-16 |
2002-05-23 |
California Institute Of Technology |
Appareil et procedes pour effectuer des dosages et des criblages a haut rendement
|
WO2002090600A2
(fr)
|
2001-05-08 |
2002-11-14 |
Darwin Molecular Corporation |
Methode de regulation de la fonction immune chez les primates a l'aide de la proteine foxp3
|
EP1406493A4
(fr)
|
2001-06-11 |
2006-06-14 |
Xenoport Inc |
Administration d'agents via le transporteur de peptides pept-2
|
US8506959B2
(en)
|
2002-11-01 |
2013-08-13 |
Neotope Biosciences Limited |
Prevention and treatment of synucleinopathic and amyloidogenic disease
|
TW200509968A
(en)
|
2002-11-01 |
2005-03-16 |
Elan Pharm Inc |
Prevention and treatment of synucleinopathic disease
|
AU2003300817A1
(en)
|
2002-11-21 |
2004-06-18 |
Celltech R And D, Inc. |
Modulating immune responses
|
PL210174B1
(pl)
|
2002-11-27 |
2011-12-30 |
Irm Llc |
Sposób indukowania in vitro apoptozy komórek nowotworowych, przeciwciało anty-DR5 do zastosowania w tym sposobie, kompozycja farmaceutyczna i komórka zwierzęca wykazująca ekspresję kwasu nukleinowego kodującego to przeciwciało
|
RU2390350C2
(ru)
|
2003-02-01 |
2010-05-27 |
Ньюралаб Лимитед |
Активная иммунизация для создания антител к растворимому а-бета
|
WO2004092179A1
(fr)
*
|
2003-04-14 |
2004-10-28 |
Nippon Soda Co. Ltd. |
Derive spiro, procede de production et antioxydant
|
US7358331B2
(en)
|
2003-05-19 |
2008-04-15 |
Elan Pharmaceuticals, Inc. |
Truncated fragments of alpha-synuclein in Lewy body disease
|
EP2361928B1
(fr)
|
2003-05-19 |
2017-04-26 |
Prothena Biosciences Limited |
Fragments tronqués d'alpha-synucléines dans une maladie de corps de Lewy
|
US20060162014A1
(en)
|
2003-07-07 |
2006-07-20 |
Jaffe Eileen K |
Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
|
US8153410B2
(en)
|
2003-07-07 |
2012-04-10 |
Fox Chase Cancer Center |
Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules
|
BRPI0415165A
(pt)
*
|
2003-10-01 |
2007-01-09 |
Adolor Corp |
composto heterocìclico espirocìclico, composição farmacêutica, método para ligar receptores opióides, métodos para prevenir ou tratar dor, disfunção gastrointestinal, um distúrbio do trato urogenital, um distúrbio imunomodulatório, um distúrbio inflamatório, um distúrbio de função respiratória, ansiedade, distúrbio do humor, um distúrbio relacionado a estresse, distúrbio do sistema nervoso simpático, tosse, e um distúrbio motor, método para tratar uma lesão traumática ao sistema nervoso central, métodos para prevenir ou tratar acidente vascular, arritmia cardìaca, glaucoma, e disfunção sexual, métodos para tratar uma condição selecionada do grupo consistindo de choque, edema cerebral, isquemia cerebral, déficit cerebral após cirurgia cardìaca (bypass) e enxerto, lupus eritematoso sistêmico, doença de hodgkin, doença de sjogren, epilepsia, e rejeição em transplantes de órgão e enxertos de pele, e para tratar dependência de substáncias, métodos para melhorar a sobrevivência de órgãos e células, e cardioproteção após infarto do miocárdio, métodos para reduzir a necessidade de anestesia, para produzir ou manter um estado anestésico, derivado radiomarcado de um composto, derivado isotopicamente marcado de um composto, composto e método de diagnóstico por imagem
|
US8187874B2
(en)
|
2003-10-27 |
2012-05-29 |
Vertex Pharmaceuticals Incorporated |
Drug discovery method
|
EA009559B1
(ru)
|
2003-12-17 |
2008-02-28 |
Элан Фармасьютикелз, Инк. |
КОНЪЮГАТЫ Aβ ИММУНОГЕННЫХ ПЕПТИДНЫХ НОСИТЕЛЕЙ И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
|
KR101157694B1
(ko)
|
2003-12-17 |
2012-06-20 |
와이어쓰 엘엘씨 |
면역원성 펩티드 캐리어 컨쥬게이트 및 이의 제조 방법
|
WO2006135382A2
(fr)
|
2004-08-04 |
2006-12-21 |
Chemocentryx, Inc. |
Activites enzymatiques dans une inflammation mediee par des chimiokines
|
EA013752B1
(ru)
|
2004-08-09 |
2010-06-30 |
Элан Фармасьютикалз, Инк. |
Предупреждение и лечение синуклеинопатических и амилоидогенных заболеваний
|
ATE526421T1
(de)
|
2005-02-14 |
2011-10-15 |
Univ Iowa Res Found |
Verfahren und reagenzien zur behandlung und diagnose von altersbedingter makuladegeneration
|
AU2006270145B2
(en)
|
2005-07-19 |
2011-04-14 |
Msd K.K. |
Spirochromanone derivatives as acetyl coenzyme a carboxylase (ACC) inhibitors
|
US8193328B2
(en)
|
2005-09-08 |
2012-06-05 |
Philadelphia Health & Education Corporation |
Identification of modulators of serine protease inhibitor Kazal and their use as anti-cancer and anti-viral agents
|
CN101309923A
(zh)
*
|
2005-11-14 |
2008-11-19 |
索尔瓦药物有限公司 |
作为碳酸酐酶抑制剂的n-氨磺酰基-n’-苯并吡喃哌啶
|
AR057570A1
(es)
|
2005-11-14 |
2007-12-05 |
Solvay Pharm Gmbh |
Derivados de n-sulfamoil-n'-benzopiranopiperidinas espirocondensadas, composiciones farmaceuticas que los comprenden, un procedimiento para su preparacion y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por las isoenzimas anhidrasas carbonicas subtipos ii y/o
|
EP2287327B1
(fr)
|
2006-03-06 |
2013-06-05 |
Ceetox Inc. |
Procédés in vitro de dépistage de la toxicité de médicament antitumoral
|
JP2009538924A
(ja)
|
2006-06-01 |
2009-11-12 |
エラン ファーマシューティカルズ,インコーポレイテッド |
Appの神経活性断片
|
EP2120569B1
(fr)
|
2007-01-12 |
2013-08-14 |
Merck Sharp & Dohme Corp. |
Dérivés spirochromanone
|
PE20081559A1
(es)
|
2007-01-12 |
2008-11-20 |
Merck & Co Inc |
DERIVADOS DE ESPIROCROMANONA SUSTITUIDOS COMO INHIBIDORES DE ACETIL CoA CARBOXILASA
|
JP5558834B2
(ja)
|
2007-02-23 |
2014-07-23 |
ヤンセン アルツハイマー イミュノセラピー |
シヌクレイノパチーおよびアミロイド形成疾患(amyloidogenicdisease)の予防および処置
|
HUE043966T2
(hu)
|
2007-02-23 |
2019-09-30 |
Prothena Biosciences Ltd |
Szinukleinopátiás és amiloidogén betegség megelõzése és kezelése
|
EP2231181B1
(fr)
|
2007-12-17 |
2016-02-17 |
Marfl AB |
Nouveau vaccin pour le traitement de troubles liés à une mycobactérie
|
CA2710984C
(fr)
|
2007-12-28 |
2018-05-29 |
Elan Pharmaceuticals, Inc. |
Traitement et prophylaxie de l'amylose
|
US20090235369A1
(en)
|
2007-12-31 |
2009-09-17 |
Baxter Healthcare S.A. |
Transgenic Non-Human Animals Expressing Human Blood Clotting Factors and Uses Thereof
|
EP2240604B1
(fr)
|
2008-01-18 |
2012-07-25 |
North Carolina State University |
Peptides et méthodes d'utilisation comme agents thérapeutiques et agents de criblage
|
US8524730B2
(en)
|
2008-07-04 |
2013-09-03 |
Msd K.K. |
Spirochromanone carboxylic acids
|
CA2734892A1
(fr)
|
2008-08-18 |
2010-02-25 |
Seoul National University Industry Foundation |
Procede pour la lutte contre la metastase cancereuse ou la migration de cellules cancereuses par modulation du taux cellulaire de lysyl-arnt synthetase
|
KR20120001756A
(ko)
|
2009-03-13 |
2012-01-04 |
비타이 파마슈티컬즈, 인코포레이티드 |
베타세크리타아제 저해제
|
EP2443459B1
(fr)
|
2009-06-19 |
2018-12-26 |
The Arizona Board of Regents, A Body Corporate Of the State of Arizona acting for and on behalf Of Arizona State University |
Réseaux de composés pour profilage d'échantillon
|
WO2011106414A1
(fr)
|
2010-02-24 |
2011-09-01 |
Dillard Lawrence W |
Inhibiteurs de la bêta-secrétase
|
HUE028983T2
(en)
|
2010-05-06 |
2017-01-30 |
Vertex Pharma |
Heterocyclic chromene-spirocyclic piperidine amides as ion channel modulators
|
TWI520964B
(zh)
|
2011-02-02 |
2016-02-11 |
維泰克斯製藥公司 |
作為離子通道調節劑之吡咯并吡-螺環哌啶醯胺
|
AU2012217616B2
(en)
|
2011-02-18 |
2017-03-02 |
Vertex Pharmaceuticals Incorporated |
Chroman - spirocyclic piperidine amides as modulators of ion channels
|
WO2012125613A1
(fr)
|
2011-03-14 |
2012-09-20 |
Vertex Pharmaceuticals Incorporated |
Amides de pipéridine spirocycliques morpholines utilisés en tant que modulateurs de canaux ioniques
|
US8975293B2
(en)
|
2011-05-26 |
2015-03-10 |
Regents Of The University Of Michigan |
Epigenetic co-repressors of the gamma-globin gene and methods of using same
|
WO2013043012A2
(fr)
|
2011-09-22 |
2013-03-28 |
Medicinal Bioconvergence Research Center |
Nouvelle utilisation de la leucyle arnt synthétase
|
EP2748307A4
(fr)
|
2011-09-23 |
2015-08-19 |
Univ Louisville Res Found |
Procédés et compositions pour expansion de cellules et amélioration de la greffe
|
KR101398079B1
(ko)
|
2011-10-10 |
2014-05-27 |
재단법인 의약바이오컨버젼스연구단 |
글리실-티알엔에이 합성효소 및 캐드헤린을 이용한 암 예방 또는 치료제의 스크리닝 방법
|
WO2013078138A1
(fr)
|
2011-11-21 |
2013-05-30 |
OSI Pharmaceuticals, LLC |
Spectroscopie rmn du proton pour criblage biochimique
|
TWI557112B
(zh)
|
2012-03-05 |
2016-11-11 |
百靈佳殷格翰國際股份有限公司 |
β-分泌酶抑制劑
|
TW201422592A
(zh)
|
2012-08-27 |
2014-06-16 |
Boehringer Ingelheim Int |
β-分泌酶抑制劑
|
WO2014052398A1
(fr)
|
2012-09-28 |
2014-04-03 |
Vitae Pharmaceuticals, Inc. |
Inhibiteur de beta-secrétase
|
US10006919B2
(en)
|
2013-03-15 |
2018-06-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Peptide array quality control
|
US9970932B2
(en)
|
2013-03-15 |
2018-05-15 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Non-covalent patterned chemical features and use thereof in MALDI-based quality control
|
WO2016040895A1
(fr)
|
2014-09-12 |
2016-03-17 |
xxTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
Molécules d'agonistes de la signalisation wnt
|
EP3234111A1
(fr)
|
2014-12-19 |
2017-10-25 |
Regeneron Pharmaceuticals, Inc. |
Cellules souches comme modèle du diabète de type 2
|
US10758886B2
(en)
|
2015-09-14 |
2020-09-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Conditioned surfaces for in situ molecular array synthesis
|
WO2017208210A1
(fr)
|
2016-06-03 |
2017-12-07 |
Prothena Biosciences Limited |
Anticorps anti-mcam et methodes d'utilisation associées
|
EP3472201A4
(fr)
|
2016-06-20 |
2020-05-13 |
Healthtell Inc. |
Procédés pour le diagnostic différentiel de maladies auto-immunes
|
EP3472181A4
(fr)
|
2016-06-20 |
2020-05-13 |
Healthtell Inc. |
Méthodes pour le diagnostic et le traitement de maladies auto-immunes
|
US20190227082A1
(en)
|
2016-07-06 |
2019-07-25 |
Prothena Biosciences Limited |
Assay for detecting total and s129 phosphorylated alpha-synuclein
|
CA3031206A1
(fr)
|
2016-07-29 |
2018-02-01 |
Regeneron Pharmaceuticals, Inc. |
Mutations entrainant l'expression de la fibrilline 1 pour modeliser le syndrome progeroide neonatal avec lipodystrophie congenitale
|
EP3526346A1
(fr)
|
2016-10-12 |
2019-08-21 |
Janssen Biotech, Inc. |
Procédés de criblage de modulateurs d'une activité biologique de type gdf15
|
EP3538893A4
(fr)
|
2016-11-11 |
2020-09-23 |
Healthtell Inc. |
Procédés pour l'identification de biomarqueurs candidats
|
CA3061429A1
(fr)
|
2017-05-05 |
2018-11-08 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Medicaments ciblant les microtubules en tant qu'inhibiteurs de points de controle immunitaires et procedes de criblage de nouveaux inhibiteurs de points de controle immunitaires p our le traitement de cancers et de maladies infectieuses
|
CA3076371C
(fr)
|
2017-11-10 |
2022-11-22 |
Regeneron Pharmaceuticals, Inc. |
Animaux non humains comprenant une mutation de slc30a8 et procedes d'utilisation
|
EP3823979A1
(fr)
|
2018-07-20 |
2021-05-26 |
AiCuris GmbH & Co. KG |
Procédés de criblage et d'identification d'agents inhibant ou modulant le complexe de sortie nucléaire du virus de l'herpès
|
CN113966401A
(zh)
|
2019-04-10 |
2022-01-21 |
犹他大学研究基金会 |
用于治疗amd的htra1调节
|
WO2022235929A1
(fr)
|
2021-05-05 |
2022-11-10 |
Radius Pharmaceuticals, Inc. |
Modèle animal ayant une recombinaison homologue du récepteur pth1 de souris
|